Clinical Studies of mechanism on oral tolerance induction by slow oral immunothrapy
Not Applicable
Recruiting
- Conditions
- Food allergy
- Registration Number
- JPRN-UMIN000023453
- Lead Sponsor
- Department of Pediatrics, School of Medicine, Fujita Health University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1; Patients using beta-blockers, 2; patients who are pregnant at the time of the start of treatment, 3; Patient who has the unstable severe asthma, 4; Patients with systemically serious disease (malignant tumors, autoimmune diseases, immune deficiencies, severe heart disease, chronic infections, etc.), 5; patients using continuous use systemic corticosteroids or anti-cancer agents, and 6; Patients who are suffering from acute infection.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Validation of Salava specific IgA for three years
- Secondary Outcome Measures
Name Time Method Validation of Serum specific IgE for three years